Results 81 to 90 of about 5,873 (176)

High Dose AbobotulinumtoxinA for Blepharospasm: A Case Report on the Safety and Efficacy of 500 Units of AbobotulinumtoxinA. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Santoso K, Baghaei A, Dashtipour K.
europepmc   +1 more source

Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. [PDF]

World J Psychiatry
He XY, Xu MY, Feng LY, Zhang JT, Jin LZ, Jin L, Ge JC, Zhang L, Zhang WB, Zhang L, Shen H, Yan J.   +11 more
europepmc   +1 more source

Reviving Hope: Overcoming Deep Brain Stimulation Failure With Partial Cranial Nerve Radiofrequency Ablation in Primary Meige Syndrome. [PDF]

Brain Behav
Li X, Yan M, Huang B, Yu L, Liu H, Huang H, Yao M.   +6 more
europepmc   +1 more source

Levodopa-Induced Oculogyric Crisis in Multiple System Atrophy. [PDF]

J Mov Disord
Turgunkhujaev O, Bagdasarova E, Lim SY.
europepmc   +1 more source

Facial Adipostructuring With Biochemical Modulation in Chronic Peripheral Facial Paralysis: A Case Report. [PDF]

Cureus
Calfin H, Riquelme V, Velazco G, Sequera M, Castro C.   +4 more
europepmc   +1 more source

Beyond Improvement of Motor Symptoms: Central Effects of Botulinum Toxin on Anxiety and Depression in Focal Dystonia, Hemifacial Spasm, and Blepharospasm. [PDF]

Toxins (Basel)
Gilman Kuric T, Popovic Z, Matosa S, Strujic E, Gacic I, Mirosevic Zubonja T, Juric S, Pecek Prpic M, Jelusic V, Biuk D, Tomic S.   +10 more
europepmc   +1 more source

A plastic surgery approach to Meige syndrome: Botulinum toxin for rebalancing facial dystonia and aesthetics - A case report. [PDF]

JPRAS Open
Long X.
europepmc   +1 more source

Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications. [PDF]

Pain Ther
Blumenfeld AM, Rhyne C, Martinez K, Patel A, Becker Ifantides K, Singh R, Yushmanova I, Battucci S, Schwartz M, Forde G.   +9 more
europepmc   +1 more source

Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in Thailand. [PDF]

Clinicoecon Outcomes Res
Hirunwiwatkul P, Permsuwan U, Ngamkiatphaisan S, Chirapapaisan N, Sriratanaban J.   +4 more
europepmc   +1 more source

Is Current Evidence Sufficient to Establish the Efficacy of Botulinum Toxin A in Treating Persistent Dry Eye Disease? A Systematic Review and Meta-Analysis of Interventional Studies With a Critical Review Using GRADE Tool. [PDF]

Health Sci Rep
Abdollahi M, Semnani F, Vahedi H, Sobhi N, Mohammadkhani M, Nabavi A, Jafarizadeh A.   +6 more
europepmc   +1 more source